1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (1:1)

Basic Information

View in Editor

CAS Number

180200-66-2

Molecular Formula

C19H24FN3O5

Molecular Weight

804.85 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Fine Chemicals Specialty Chemicals UV Stabilizers

Agricultural Chemicals Pesticides Herbicides

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

No data available

Melting Point

185-188°C

Boiling Point

607.8°C at 760 mmHg

Density

1.386

Flash Point

321.4 oC

Solubility

Soluble in 1N NaOH at 10mg/ml

Vapor Pressure

No data available

SMILES

View in Editor

COc1c(N2CCNC(C2)C)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.COc1c(N2CCNC(C2)C)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.O.O.O

InChI

InChI=1S/C19H22FN3O4.H2O/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26;/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26);1H2

InChIKey

IJOOSVJZBQQMBV-UHFFFAOYSA-N

LogP

1.4867000000000017

Topological Polar Surface Area

262.09999999999997 Å²

Hydrogen Bond Donor/Acceptor

10 / 17

Complexity

653

Safety Information

View Safety Information

Hazard Statement

H302 Harmful if swallowed
Acute toxicity, oral

H315 Causes skin irritation
Skin corrosion/irritation

H319 Causes serious eye irritation
Serious eye damage/eye irritation

H335 May cause respiratory irritation
Specific target organ toxicity, single exposure; Respiratory tract irritation

Synonyms & References

English

Gatifloxacin sesquihydrate
1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate
1-Cyclopropyl-6-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid
1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-3-QUINOLINECARBOXYLIC ACID
1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid sesquihydrate
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid trihydrate
Gatifloxacin
Gatifloxacin formic acid ethyl ester
Gatifloxacin Mono
Gatifloxacin Tablet
(±)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid sesquihydrate
TEQUIN
(+-)-1-C
AKOS NCG1-0010
Gatifloxacin (300 mg)
Gatifloxacin Monohydrate
1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carbo
AM-1155 sesquihydrate
BMS-206584 sesquihydrate
PD135432 sesquihydrate

MDL Number

MFCD22373645

Customs Code

2933990090

FAQ

What are the physical and chemical properties of 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2)?

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate is a solid compound with a molecular weight of approximately 409.17 g/mol. It has a crystalline form and is slightly soluble in water. The compound displays moderate reactivity, particularly towards basic conditions. It is characterized by its pKa value of around 7.5, indicating a weak basic nature.

How is 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2) typically synthesized?

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2) is typically synthesized through multi-step organic reactions involving the condensation of appropriate precursors. The synthesis involves the use of acidic catalysts and requires careful control of reaction conditions to achieve high yield and selectivity. The process often includes reactions such as esterification, nucleophilic substitution, and condensation reactions.

What industries use 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2)?

1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2) is primarily used in the pharmaceutical industry for the development of new drugs. It may also find applications in the polymer industry for the synthesis of novel materials with specific properties. Additionally, it could be used in the sensor industry for its unique chemical and physical properties.

What precautions should be taken when handling 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2)?

When handling 1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid hydrate (CAS: 180200-66-2), it is important to use personal protective equipment (PPE) such as gloves, safety goggles, and lab coat to protect against potential skin and eye irritation. The compound should be stored in a dry, well-ventilated area. In case of a spill, immediate action should be taken to clean up the area using appropriate absorbent materials and follow safety protocols. Always refer to the safety data sheet (SDS) for detailed handling and disposal instructions.